Investigators Research Group

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Obesity2 trials
• Chronic kidney disease1 trial
• Gout1 trial
• Type 1 diabetes1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Completed1 trial
• Suspended1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Crystalys Therapeutics1 trial
• Fractyl Health Inc.1 trial

Running trials

• Recruiting

  A Study of Dotinurad Versus Allopurinol in Participants With Gout

  NCT07089875· Phase 3· Crystalys Therapeutics· Source

  Contact: Kenneth Maynard, MD

• Recruiting

  A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  NCT06897475· Phase 2· Eli Lilly and Company· Source

  Contact: Kenneth Maynard (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gout1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source